The NIH intramural research program has shifted all non-mission-critical laboratory operations to a maintenance phase in order to promote physical distancing and diminished transmission risk of COVID-19. Effective Monday, March 23, 2020, only mission-critical functions within NIH research laboratories will be supported.
NIH accomplishments in the prevention, diagnosis, and treatment of human disease. These include progress on two Ebola vaccines, a bionic pancreas to treat type 1 diabetes, and a genetic test that improves blood thinner dosing.
NIH findings with potential for enhancing human health include understanding how dietary factors influence disease risk, combatting the epigenetic effects of outdoor air pollution, and methods to detect prions in blood and skin.
Noteworthy NIH advances in basic research include a 3-D model of human brain development and disease, a virus linked to food sensitivity, and a new role discovered for the thalamus.
NIH accomplishments in the prevention, diagnosis, and treatment of human disease. These include a way to restore blood sugar control in type 1 diabetes, food allergy prevention, and an experimental malaria vaccine.
Noteworthy NIH advances in basic research include an expanded map of the human brain, nanoparticles that convert white fat to calorie-burning brown fat, and a 3-D cell culture model of the placenta.
NIH accomplishments in the prevention, diagnosis, and treatment of human disease. These include a test to tailor breast cancer tumor treatments, a noninvasive treatment to help paralyzed men gain movement, and a tool that may predict suicide risk.
NIH findings with potential for enhancing human health include advances in Ebola research, progress in fighting HIV, and the development of custom 3-D printed nerve scaffolds to aid tissue regeneration.
Noteworthy NIH advances in basic research include charting human genetic variation across the globe, the discovery of lymphatic vessels in the central nervous system, and insights into energy-burning fat cells.
